United States

Endo International PLC (ENDP.O)

ENDP.O on Nasdaq

16 Aug 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENDP.O


Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that... (more)


Beta: 0.64
Market Cap(Mil.): $1,942.64
Shares Outstanding(Mil.): 223.29
Dividend: --
Yield (%): --


  ENDP.O Industry Sector
P/E (TTM): -- 31.12 32.38
EPS (TTM): -19.68 -- --
ROI: -35.02 15.33 14.90
ROE: -124.07 16.36 16.15

U.S. asks drug maker Endo to withdraw opioid amid abuse crisis

WASHINGTON As the United States battles a growing opioid abuse crisis, the Food and Drug Administration on Thursday asked Endo International Plc to withdraw from the market its long-lasting opioid painkiller, Opana ER, sending Endo's shares down more than 12 percent.

Jun 08 2017

FDA asks Endo to withdraw Opana ER opioid, shares fall

June 8 The U.S. Food and Drug Administration said on Thursday it has asked Endo International to withdraw from the market its long-lasting opioid painkiller Opana ER, sending the company's shares down as much as 13 percent.

Jun 08 2017

Earnings vs. Estimates